Showing results (31-40 of 366) with videos related to

Sort By:
Pageof 37
Journal of Neural Transmission. Supplementum|January 1, 1987
R-(-)-deprenyl (Selegiline, Movergan) facilitates the activity of the nigrostriatal dopaminergic neuronJ Knoll
Progress in Clinical and Biological Research|January 1, 1985
Satietin, a blood-borne glycoprotein in the regulation of food intakeJ Knoll
Journal of the American Geriatrics Society|August 1, 1992
(-)Deprenyl-medication: a strategy to modulate the age-related decline of the striatal dopaminergic systemJ Knoll
Pharmacology & Toxicology|March 14, 1998
(-)Deprenyl (selegiline), a catecholaminergic activity enhancer (CAE) substance acting in the brainJ Knoll
Acta Neurologica Scandinavica. Supplementum|January 1, 1989
The pharmacology of selegiline ((-)deprenyl). New aspectsJ Knoll
Experimental Gerontology|July 1, 1997
Sexual performance and longevityJ Knoll
Journal of Neural Transmission. Supplementum|January 1, 1986
The pharmacology of (-)deprenylJ Knoll
Wiener Medizinische Wochenschrift. Supplement|January 1, 1986
[Medicamentous strategy for improving the quality of life in the senescence]J Knoll
Neurobiology (Budapest, Hungary)|November 4, 2000
(-)Deprenyl (Selegiline): past, present and futureJ Knoll
CNS Drug Reviews|October 19, 2001
Antiaging compounds: (-)deprenyl (selegeline) and (-)1-(benzofuran-2-yl)-2-propylaminopentane, [(-)BPAP], a selective highly potent enhancer of the impulse propagation mediated release of catecholamine and serotonin in the brainJ Knoll
Pageof 37